Literature DB >> 12720006

Ischemic optic neuropathy after endoscopic sinus surgery: a case report.

Jin-Chin Lee1, Ping-I Chuo, Ming-Wang Hsiung.   

Abstract

For the past 2 decades, endoscopic sinus surgery (ESS) has proven effective for treating paranasal sinus disease. Orbital complications of varying degrees, from mild orbital hematoma to catastrophic blindness, have been widely reported. However, defects of the visual field resulting from post-ESS ischemic optic neuropathy (ION) has not to our knowledge been reported in the literature. We were presented with a 51-year-old male patient suffering from loss of sight following an otherwise uneventful ESS. ION is a rare condition, characterized by acute or subacute postoperative loss of sight. The major risks for developing ION include intraoperative anemia, hypotension and systemic illnesses such as hypertension, diabetes or renal failure. Otorhinolaryngologists should be aware that this condition may occur following an uncomplicated ESS procedure, and patients should be given prompt opthalmological consultation when loss of sight is diagnosed postoperatively. Early aggressive and rapid correction of blood pressure and blood transfusions may be helpful in the treatment of patients who develop ION after surgery.

Entities:  

Mesh:

Year:  2003        PMID: 12720006     DOI: 10.1007/s00405-003-0612-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  11 in total

1.  UNEXPLAINED BLINDNESS AND OPTIC ATROPHY FOLLOWING RETINAL DETACHMENT SURGERY.

Authors:  W H JARRETT; R J BROCKHURST
Journal:  Arch Ophthalmol       Date:  1965-06

2.  Orbital complications secondary to endoscopic sinus surgery.

Authors:  R W Neuhaus
Journal:  Ophthalmology       Date:  1990-11       Impact factor: 12.079

3.  Fatal and other major complications of endoscopic sinus surgery.

Authors:  A J Maniglia
Journal:  Laryngoscope       Date:  1991-04       Impact factor: 3.325

4.  Anemia and hypotension as contributors to perioperative loss of vision.

Authors:  R H Brown; J F Schauble; N R Miller
Journal:  Anesthesiology       Date:  1994-01       Impact factor: 7.892

5.  Blindness and intranasal endoscopic ethmoidectomy: prevention and management.

Authors:  J A Stankiewicz
Journal:  Otolaryngol Head Neck Surg       Date:  1989-09       Impact factor: 3.497

6.  Ophthalmic complications of sinus surgery.

Authors:  D R Buus; D T Tse; B K Farris
Journal:  Ophthalmology       Date:  1990-05       Impact factor: 12.079

7.  Ischemic optic neuropathy following lumbar spine surgery. Case report.

Authors:  A G Lee
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

8.  Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group.

Authors: 
Journal:  JAMA       Date:  1995-02-22       Impact factor: 56.272

9.  Salvage of vision after hypotension-induced ischemic optic neuropathy.

Authors:  S E Connolly; K B Gordon; J C Horton
Journal:  Am J Ophthalmol       Date:  1994-02-15       Impact factor: 5.258

10.  Endoscopic management of lesions of the sella turcica.

Authors:  D S Sethi; P K Pillay
Journal:  J Laryngol Otol       Date:  1995-10       Impact factor: 1.469

View more
  3 in total

Review 1.  [Loss of vision after non-ophthalmic surgery: systematic review of the literature on incidence, pathogenesis, treatment and prevention].

Authors:  A Torossian; J Schmidt; W Schaffartzik; H Wulf
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

Review 2.  Danger points, complications and medico-legal aspects in endoscopic sinus surgery.

Authors:  W Hosemann; C Draf
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

3.  Ophthalmic complications of endoscopic sinus surgery.

Authors:  Malgorzata Seredyka-Burduk; Pawel Krzysztof Burduk; Malgorzata Wierzchowska; Bartlomiej Kaluzny; Grazyna Malukiewicz
Journal:  Braz J Otorhinolaryngol       Date:  2016-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.